Atlas Trials

Prospective Phase II Clinical Study of Stereotactic Body Proton Therapy (SBPT) for Lung Cancer

Clinical trial NCT07412327 · RECRUITING

Trial details

NCT number
NCT07412327
Sponsor
Guangzhou Concord Cancer Center
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Early-Stage Lung CancerLung Cancer
Start date
2026-02-24
Primary completion
2029-07-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.